Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (11): 71-75.doi: 10.6040/j.issn.1671-7554.0.2020.1127

Previous Articles     Next Articles

Expression and clinical significance of exosomal long non-coding RNA OGFRP1 in 84 cases of non-small cell lung cancer

LIU Xiaojing, XIA Xiyan, XIAO Ke, CHEN Wendan, ZHUANG Xuewei   

  1. Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2020-11-04

PDF (PC)

282

Abstract: Objective To explore the expression and clinical significance of long non-coding RNA(lncRNA)OGFRP1 in serum exosomes of non-small cell lung cancer(NSCLC). Methods A total of 84 cases preliminarily diagnosed as NSCLC and 84 healthy controls were enrolled. The serum exosomes were extracted and identified, the RNA was extracted, and lncRNA expression was detected. The sensitivity, specificity and diagnostic accuracy of lncRNA OGFRP1 were statistically analyzed. The relationship between the lncRNA OGFRP1 expression and clinicopathological factors were analyzed. Results All cases were pathologically confirmed as NSCLC. lncRNA OGFRP1 was highly expressed in NSCLC(χ2=96.459, P<0.001). With pathological diagnosis as the gold standard, the sensitivity, specificity and accuracy of lncRNA OGFRP1 in the auxiliary diagnosis of NSCLC were 89.4%, 87.9% and 89.4%, respectively, higher than those of carcino-embryonic antigen(P<0.01). The relative expression of lncRNA OGFRP1 in serum exosomes was significantly associated with lymph node metastasis(P=0.034)and T stage(P=0.030)in NSCLC patients. Conclusion The detection of exosomal lncRNA OGFRP1 has high sensitivity, specificity and accuracy in the diagnosis of NSCLC, which can be used as a novel tumor marker for early screening, diagnosis and staging of NSCLC.

Key words: Non-small cell lung cancer, Long non-coding RNA OGFRP1, Exosome, Carcino-embryonic Antigen

CLC Number: 

  • R734.2
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(1): 7-34.
[2] Anglim PP, Alonzo TA, Laird-Offringa IA. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update [J]. Mol Cancer, 2008, 7: 81. doi: 10.1186/1476-4598-7-81.
[3] Boolell V, Alamgeer M, Watkins DN, et al. The evolution of therapies in non-small cell lung cancer [J]. Cancers(Basel), 2015,7(3):1815-1846.
[4] Brainard J, Farver C. The diagnosis of non-small cell lung cancer in the molecular era [J]. Mod Pathol, 2019, 32(Suppl 1): 16-26.
[5] Kadara H, Scheet P, Wistuba II, et al. Early events in the molecular pathogenesis of lung cancer [J]. Cancer Prev Res(Phila), 2016, 9(7): 518-527.
[6] Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression [J]. Genome Res, 2012, 22(9): 1775-1789.
[7] Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for the ENCODE Project [J]. Genome Res, 2012, 22(9): 1760-1774.
[8] Chen R, Xu X, Qian Z, et al. The biological functions and clinical applications of exosomes in lung cancer [J]. Cell Mol Life Sci, 2019, 76(23): 4613-4633.
[9] Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses [J]. Nucleic Acids Res, 2017, 45(W1): W98-W102.
[10] Fong KM, Minna JD. Molecular biology of lung cancer: clinical implications [J]. Clin Chest Med, 2002, 23(1): 83-101.
[11] Ramalingam S, Belani C. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions [J]. Oncologist, 2008(Suppl 1): 5-13. doi: 10.1634/theoncologist.13-S1-5.
[12] Kalluri R. The biology and function of exosomes in cancer [J]. J Clin Invest, 2016, 126(4): 1208-1215.
[13] Ludwig AK, Giebel B. Exosomes: small vesicles participating in intercellular communication [J]. Int J Biochem Cell Biol, 2012, 44(1): 11-15.
[14] Gross JC, Chaudhary V, Bartscherer K, et al. Active wnt proteins are secreted on exosomes [J]. Nat Cell Biol, 2012, 14(10): 1036-1045.
[15] Boelens MC, Wu TJ, Nabet BY, et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways [J]. Cell, 2014, 159(3): 499-513.
[16] Hassanpour M, Rezabakhsh A, Rezaie J, er al. Exosomal cargos modulate autophagy in recipient cells via different signaling pathways [J]. Cell Biosci, 2020, 10: 92. doi: 10.1186/s13578-020-00455-7.
[17] Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA [J]. Nat Rev Mol Cell Biol, 2018, 19(3): 143-157.
[18] Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses [J]. Genes Dev, 2011, 25(18): 1915-1927.
[19] Gloss BS, Dinger ME. The specificity of long noncoding RNA expression[J]. Biochim Biophys Acta, 2016, 1859(1): 16-22.
[20] Arcaro A. Targeting PI3K/mTOR signaling in cancer [J]. Front Oncol, 2014, 4: 84. doi: 10.3389/fonc.2014.00084.
[21] Tang XD, Zhang DD, Jia L, et al. lncRNA AFAP1-AS1 promotes migration and invasion of non-small cell lung cancer via up-regulating IRF7 and the RIG-I-Like receptor signaling pathway [J]. Cell Physiol Biochem, 2018, 50(1): 179-195.
[22] Cui Y, Zhang F, Zhu C, et al. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway [J]. Oncotarget, 2017, 8(11): 17785-17794.
[23] Weber DG, Johnen G, Casjens S, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer [J]. BMC Res Notes, 2013, 6: 518. doi: 10.1186/1756-0500-6-518.
[24] Yu H, Xu Q, Liu F, et al. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas [J]. J Thorac Oncol, 2015, 10(4): 645-654.
[25] Wang P, Lu S, Mao H, et al. Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs [J]. Lung Cancer, 2015, 88(2): 147-153.
[1] SUN Qijing, CHEN Fangfang, LI Chunxiao, ZHANG Caiqing. Clinical value of PNI and HGB in evaluating the prognosis of the middle to late stage non-small cell lung cancer patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 55-59.
[2] PENG Yue, FENG Zhen, XIE Hounai, WANG Hui, LI Meng, REN Wangang, LIU Tong, PENG Zhongmin. Surgical treatment for 61 patients with multiple lung lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 42-46.
[3] WANG Lili, HUO Bin, WANG Lei, WANG Hao, HOU Dingkun, HUO Xiaodong, WANG Jinhuan, ZANG Li, CAO Qiang, CHAI Shude, WANG Haitao. Meta-analysis and system evaluation of 125I implantation in the treatment of early lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 76-83.
[4] GAO Ang, WANG Shijiang, FU Zheng, SUN Xindong, YU Jinming, MENG Xue. A feasibility study for boost target delineation using 18F-FDG PET/CT in local advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 73-77.
[5] YANG Lu, LIU Yanguo, LI Jisheng, WANG Xiuwen. Effect of bufalin on chemosensitivity to cisplatin in non-small cell lung cancer and the underlying mechanisms [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 6-11.
[6] GAO Peng, SHEN Fangzhen, XIAO Wenjing, XIU Yuande, ZHOU Lingling. Correlation between the expressions of Runx2 and Ezrin and postoperative metastasis in patients with stage IB non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(1): 63-66.
[7] XIAO Fang, JIANG Weidong, WANG Xiaohong, QIN Aiqiong, HAN Min, CHEN Li. Extraction and identification of mouse islet microvascular endothelial cells (MS-1)-derived exosomes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(1): 6-9.
[8] YUAN Zhiping, MOU Huaping, CHEN Jialian, DENG Li. Expressions and significances of serum hepatic cancer-derived growth factor and vascular endothelial growth factor in patients with non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 63-66.
[9] LIU Shan-wen1, WANG Fu1, LI Bin2, GENG Hai-hua3, LI Cai-e4, XU Zhe5, LI Rui1, XIAO Jie1, ZHANG Sen1, JI Xiao-ping1. Isolation of rat bone marrow mesenchymal stem cell-derived exosome and the uptake of exosome by H9C2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 1-7.
[10] ALIMUJIANG·Stiwaerdi, ZHANG Tao, PATIGULI·Aerxiding, LIU Li. Clinical analysis of recombinant human endostatin combined with gemcitabine and  cisplatin therapy in advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 95-98.
[11] DU Lu-tao1, WANG Chuan-xin1, XIAO xiao-yan2, ZHENG Ni1, ZHANG Xin1, ZHANG Xu-hua3, WANG Li-li1, WANG Shun1, DONG Zhao-gang1. The significance of detection of plasm sHLA-G for early diagnosis of gastric cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 125-129.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd